Cargando…
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379128/ https://www.ncbi.nlm.nih.gov/pubmed/33037970 http://dx.doi.org/10.1007/s10620-020-06638-z |
| _version_ | 1783740946482987008 |
|---|---|
| author | Panaccione, Remo Isaacs, John D. Chen, Lea Ann Wang, Wenjin Marren, Amy Kwok, Kenneth Wang, Lisy Chan, Gary Su, Chinyu |
| author_facet | Panaccione, Remo Isaacs, John D. Chen, Lea Ann Wang, Wenjin Marren, Amy Kwok, Kenneth Wang, Lisy Chan, Gary Su, Chinyu |
| author_sort | Panaccione, Remo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8379128 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83791282021-09-02 Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials Panaccione, Remo Isaacs, John D. Chen, Lea Ann Wang, Wenjin Marren, Amy Kwok, Kenneth Wang, Lisy Chan, Gary Su, Chinyu Dig Dis Sci Correction Springer US 2020-10-10 2021 /pmc/articles/PMC8379128/ /pubmed/33037970 http://dx.doi.org/10.1007/s10620-020-06638-z Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Panaccione, Remo Isaacs, John D. Chen, Lea Ann Wang, Wenjin Marren, Amy Kwok, Kenneth Wang, Lisy Chan, Gary Su, Chinyu Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials |
| title | Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials |
| title_full | Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials |
| title_fullStr | Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials |
| title_full_unstemmed | Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials |
| title_short | Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials |
| title_sort | correction to: characterization of creatine kinase levels in tofacitinib‑treated patients with ulcerative colitis: results from clinical trials |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379128/ https://www.ncbi.nlm.nih.gov/pubmed/33037970 http://dx.doi.org/10.1007/s10620-020-06638-z |
| work_keys_str_mv | AT panaccioneremo correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT isaacsjohnd correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT chenleaann correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT wangwenjin correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT marrenamy correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT kwokkenneth correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT wanglisy correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT changary correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials AT suchinyu correctiontocharacterizationofcreatinekinaselevelsintofacitinibtreatedpatientswithulcerativecolitisresultsfromclinicaltrials |